THE SINGLE BEST STRATEGY TO USE FOR PINK SUBUTEX

The concomitant use of buprenorphine and CYP3A4 inducers can lower the plasma focus of buprenorphine [see CLINICAL PHARMACOLOGY], possibly leading to diminished efficacy or onset of the withdrawal syndrome in individuals who have formulated physical dependence to buprenorphine.Use this medication often in an effort to receive the most benefit from